![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, February 07, 2023 6:18:57 PM
The problem I have with this change of its core business is not the idea of having a non-invasive way of diagnosing cancer in the lymph nodes, this is a wonderful achievement, if it is proven out with more than just a few patients in a seemingly difficult study now going on for three years?
Proulx fails to mention the risks, which are many, starting with the competiton with more $$$ who can quickly capitalize on this achievement with more resources and very skilled management. He does add this in the IBX website, but I see this as more cover his bu-- after all how many investors actually look at the site on a daily basis, when you have the magical oz behind the curtain, pumping out videos.
What are the main risks associated with this shift?
We will face the same risks associated with new product entry in established and entrenched markets where low-cost ultrasound is ubiquitous despite performance limitations. However, we believe introduction for use with MRI will reduce those risks compared to introducing a new technology. We are not aware of other players trying to address the unmet medical need that we are by molecular imaging and hence expect to benefit from being the first mover and potentially obtain regulatory exclusivity in certain jurisdictions if approved first.
Same risks as new products
Not aware of competitors, which means there is nothing proprietary that IBX has that others can't quickly copy.
So how many years now and millions and millions spent on a technology that he couldn't make work and now he realizes that the non-proprietary nanoparticles work with MRI. I hope I am dead wrong and the SP flies to the moon, but without a partner like Siemens or some big name, this will be another nano particle company, not what I invested $$ into.
Recent MHTX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 07:12:38 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 07:44:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:04:24 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM